Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Parissa Tabrizian"'
Publikováno v:
International Journal of Surgery. 82:61-69
The Milan criteria have been the cornerstone of selection policies for patients with hepatocellular carcinoma (HCC) awaiting liver transplantation (LT) globally for over two decades. Many groups have proposed the transplantation of patients with larg
Autor:
Bachir Taouli, Sara Lewis, Parissa Tabrizian, Olamide Omidele, Karen M. Lee, Myron Schwartz, Stefanie J. Hectors, James S. Babb, Michael J. King
Publikováno v:
Cancer Imaging
Cancer Imaging, Vol 20, Iss 1, Pp 1-15 (2020)
Cancer Imaging, Vol 20, Iss 1, Pp 1-15 (2020)
Background To assess the performance of imaging features, including radiomics texture features, in predicting histopathologic tumor grade, AJCC stage, and outcomes [time to recurrence (TTR) and overall survival (OS)] in patients with intrahepatic cho
Autor:
Umut Sarpel, Yaniv Berger, Parissa Tabrizian, Spiros P. Hiotis, Daniel M. Labow, John Mandeli, Samantha Aycart, Marina Heskel, Yahel Agmon
Publikováno v:
Journal of Surgical Oncology. 113:432-437
Background We examined outcomes of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) combined with liver resection. Methods All patients undergoing CRS/HIPEC between 2007 and 2014 were retrospectively
Autor:
Parissa Tabrizian, Fabian M. Johnston, Kiran K. Turaga, Daniel M. Labow, Umut Sarpel, Thejus T. Jayakrishnan, Anthony J. Zacharias, Samantha Aycart
Publikováno v:
Journal of Surgical Oncology. 111:1035-1040
Introduction Diagnostic laparoscopy (DL), which can predict complete cytoreduction (CC), is often considered unfeasible in patients with Peritoneal metastases (PM) due to a hostile abdomen, prior surgeries, incomplete assessment or risk of port site
Autor:
Umut Sarpel, Ghalib Jibara, Daniel M. Labow, Robert Sweeney, Parissa Tabrizian, Myron Schwartz, Bernardo Franssen
Publikováno v:
Journal of Surgical Oncology. 110:786-790
Background and Objectives The benefit of Sorafenib is not well described in patients with peritoneal hepatocellular carcinoma (HCC). Although cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have shown favorable outco
Autor:
Spiros P. Hiotis, Brian Shrager, Ghalib Jibara, Myron Schwartz, Parissa Tabrizian, Daniel M. Labow
Publikováno v:
Journal of Surgical Oncology. 107:111-117
Background and Objectives Few Western centers have surgically treated a high volume of large hepatocellular carcinoma 10 cm or more in diameter. The study aim was to analyze a large Western cohort of these patients, and to present our outcomes in the
Autor:
David B. Wax, Bryan Hill, Hung-Mo Lin, Jessica A. Zerillo, Myron Schwartz, Samuel DeMaria, Parissa Tabrizian
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 42(10)
Background Studies have suggested that blood loss can be reduced during liver resection by monitoring and maintaining low central venous pressure (CVP) through fluid restriction or other means, but such a strategy carries risks to the patient includi
Publikováno v:
Breast cancer (Tokyo, Japan). 18(4)
The management of multiple synchronous groups of benign-appearing calcifications in patients with a diagnosis of breast cancer or a high-risk lesion requiring excision is unclear. The purpose of this study was to examine the results of biopsies of sy
Publikováno v:
World Journal of Gastroenterology. 20:10223
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and leading cause of death among patients with cirrhosis. Treatment guidelines are based according to the Barcelona Clinic Liver Cancer staging system. The choice among therapeu